NorthWest Biotherapeutics Inc (NWBO)

[TheDiscoverer84]

I loved Mrvnng's (sp) post. Great piece of work. And the positivity is shining through.

However, I'm feeling exhausted, not to say anxious, waiting and waiting after Data Lock for the peer reviewed journal article. Did they move the printing press to Mars or something. Or, do we have a 'sleeper agent' at the unknown Journal whose job it is to delay and delay the NWBO publication? People will do strange things for the right amount of money. Maybe a top researcher has sold out and won't be publishing and thus is delaying publication unnecessarily?

Second, this leisurely pace may come back to bit us, bad. Really bad. Here are two articles that are "scary as hell" to me. Reminds me of something called "technological lock" that was occurring (and still occurs today) when computers, programs, internet, etc., were all getting going and the fast movers locked up the future (MSFT was a case in point). SO many technology start-ups no longer exist, locked out because everyone bought one technology and dropped all the rest.

So, is the Eli Lilly product a form of "treatment lock" that blindsides NWBO mgmt and makes us irrelevant? All twelve patients were CURED of their rectal cancer with followup of 6 to 25 months!!! And they're saying, (speculating?) it will apply to all solid state tumors just as DCVax-L? Only, DCVax-L is not a Cure but rather a Life Extender. Everyone will want a 'cured life' rather than an 'extended life'. And HOW, exactly, did Lilly get their results published so fast while we dawdle along?

Here are two URL's (and some paragraphs from the Eli Lilly article) to articles showing others are not standing still. Will waiting for publication end up making our treatment irrelevant? My aging (85 yr old) brain wants to bring up the race between two robot surgical companies, Robodoc and Intuitive Surgical. I bet on the wrong horse. Intuitive Surgical won big. https://www.analyticsinsight.net/top-10-robotic-surgical-companies-in-2021-all-over-the-world/

[A cancer trial has reportedly become the first in the world to completely remove the disease in every patient, according to a study published Sunday in the New England Journal of Medicine.

Dostarlimab is already approved by the U.S. Food and Drug Administration for use in the treatment of adult patients with mismatch repair-deficient recurrent or advanced solid tumors. Rectal cancer is an off-label use, according to Medscape.

Furthermore, the patients continued to show no signs of cancer during follow-ups ranging from 6 to 25 months and have not had to undergo surgery or receive radiation and chemotherapy.

https://www.theepochtimes.com/cancer-trial-using-monoclonal-antibody-finds-remission-in-every-patient-report_4514295.html?utm_source=Morningbrief-ai&utm_medium=email&utm_campaign=mb-2022-06-07-ai&est=JEXOcfWYhbvRX8kLv4wUImoTFbkZPaJfaJvvnAm2AsuJtkuFyngADSJgPj0F6QY%3D

AND

https://www.theepochtimes.com/cancer-patients-own-cells-used-in-3d-printed-tumors-to-test-treatments_3955019.html

I'm sorry but this really looks like 'bad news' for NWBO and great news for mankind. Sigh. Maybe it is time to buy Eli Lilly despite the "late to the game" feeling their current stock chart gives.